Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Significant between-group differences were also observed in several clinical and laboratory variables, including city residence, house renovation history, wet bleeding, neutrophil count (Neu), PCTp, C3, IgA, vitamin D (Vit_D), SIRI, and ANA (all P < 0.05).
Source: Baseline characteristics. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Risk factors analysis and validation of early treatment non-response in children with primary ITP: a multicenter retrospective cohort study
Source: Article title.
An independent external validation cohort of 78 children was additionally included to assess model discrimination.
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Risk factors analysis and validation of early treatment non-response in children with primary ITP: a multicenter retrospective cohort study
Cohort study · Frontiers in Immunology · 2026
Original publication title
Risk factors analysis and validation of early treatment non-response in children with primary ITP: a multicenter retrospective cohort study
Copyright © 2026 Li and Yan.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To identify factors associated with early non-response to first-line treatment in children with primary immune thrombocytopenia (ITP), and to develop and externally validate a prediction model.
Source: ObjectiveAbstract: What methods does the paper describe?
This multicenter retrospective cohort study included 335 children with newly diagnosed primary ITP as the derivation cohort, including 255 responders and 80 non-responders. Clinical data obtained after admission were collected. Candidate variables were screened using correlation analysis and least absolute shrinkage and selection operator (LASSO) regression, followed by multivariable logistic regression to identify factors associated with early treatment non-response. Model discrimination was evaluated using the area under the receiver operating characteristic curve (AUC). An independent external validation cohort of 78 children was additionally included to assess model discrimination.
Source: MethodsAbstract: Results
Among the 335 children, 255 (76.1%) achieved a treatment response within 14 days after first-line therapy, whereas 80 (23.9%) did not. Multivariable analysis showed that older age (OR = 1.769, 95% CI: 1.629 to 1.920, P < 0.001), higher platelet-to-lymphocyte ratio (PLR) (OR = 1.622, 95% CI: 1.112 to 2.367, P = 0.012), and antinuclear antibody (ANA) positivity (OR = 3.142, 95% CI: 1.626 to 6.071, P < 0.001) were independently associated with early treatment non-response. The combined model incorporating age, PLR, and ANA achieved an AUC of 0.831 (95% CI: 0.778 to 0.885) in the derivation cohort and 0.718 (95% CI: 0.591 to 0.845) in the independent external validation cohort.
Calibration was acceptable in both cohorts, with Hosmer: Lemeshow P values of 0.609 and 0.220 and Brier scores of 0.129 and 0.137, respectively.
Source: ResultsAbstract: Conclusion
Older age, higher PLR, and ANA positivity were independently associated with early non-response to first-line treatment within 14 days in children with newly diagnosed primary ITP. These findings may help identify children at high risk of treatment non-response and support individualized monitoring and treatment strategies.
Source: ConclusionAuthors’ abstract
Objective
To identify factors associated with early non-response to first-line treatment in children with primary immune thrombocytopenia (ITP), and to develop and externally validate a prediction model.
Methods
This multicenter retrospective cohort study included 335 children with newly diagnosed primary ITP as the derivation cohort, including 255 responders and 80 non-responders. Clinical data obtained after admission were collected. Candidate variables were screened using correlation analysis and least absolute shrinkage and selection operator (LASSO) regression, followed by multivariable logistic regression to identify factors associated with early treatment non-response. Model discrimination was evaluated using the area under the receiver operating characteristic curve (AUC). An independent external validation cohort of 78 children was additionally included to assess model discrimination.
Results
Among the 335 children, 255 (76.1%) achieved a treatment response within 14 days after first-line therapy, whereas 80 (23.9%) did not. Multivariable analysis showed that older age (OR = 1.769, 95% CI: 1.629 to 1.920, P < 0.001), higher platelet-to-lymphocyte ratio (PLR) (OR = 1.622, 95% CI: 1.112 to 2.367, P = 0.012), and antinuclear antibody (ANA) positivity (OR = 3.142, 95% CI: 1.626 to 6.071, P < 0.001) were independently associated with early treatment non-response. The combined model incorporating age, PLR, and ANA achieved an AUC of 0.831 (95% CI: 0.778 to 0.885) in the derivation cohort and 0.718 (95% CI: 0.591 to 0.845) in the independent external validation cohort.
Calibration was acceptable in both cohorts, with Hosmer: Lemeshow P values of 0.609 and 0.220 and Brier scores of 0.129 and 0.137, respectively.
Conclusion
Older age, higher PLR, and ANA positivity were independently associated with early non-response to first-line treatment within 14 days in children with newly diagnosed primary ITP. These findings may help identify children at high risk of treatment non-response and support individualized monitoring and treatment strategies.
Publication and source details
Original title: Risk factors analysis and validation of early treatment non-response in children with primary ITP: a multicenter retrospective cohort study
Mingwei Li; Mei Yan
Frontiers in Immunology · 2026
* Correspondence: Mei Yan, yan10mei25@163.comCopyright © 2026 Li and Yan.2026Li and Yanhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This work was supported by the Key Research and Development Program of the Xinjiang Uygur Autonomous Region (Grant No. 2024B03038). The project title is “Establishment of an Integrated Prevention, Diagnosis and Treatment System and Research on Key Technologies for Major Childhood Diseases in Xinjiang”. Youth Sailing Youth Project in the First Affiliated Hospital of Xinjiang Medical University of China. (Grant Number: 2022YFY-QKQN-05). This work was supported by the National Natural Science Foundation of China (Grant No. 82560033) and the Innovation and Entrepreneurship Training Program for College Students of Xinjiang (Grant No. CXCY2026001).Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:34:02.229987+00:00
DOI: 10.3389/fimmu.2026.1983623 · PMC13683604